Coave Therapeutics
Created in 2014
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
209 4,085 4,085Activities
Technologies
Entity types
Location
29 Rue du Faubourg Saint-Jacques, 75014 Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 36
SIREN
800830721Engaged corporates
7
5 1Added in Motherbase
5 years, 7 months ago
deeptech Value proposition
Coave therapeutics new brand for Horama
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases.
We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases.
Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success will provide rapid validation of our ALIGATER platform.
médecine, thérapie génique, ophtalmologie, Gene Therapy, Rare Ocular disease, and CNS diseaseOriginal language
Coave therapeutics new brand for Horama
Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases.
We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases.
Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success will provide rapid validation of our ALIGATER platform.
Coave Therapeutics – Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare ocular and CNS (Central Nervous System) diseases.
https://coavetx.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Alexion Pharmaceuticals, Inc. Pharmaceutical, Biotechnology, Biotechnology Research | Alexion Pharmaceuticals, Inc. Pharmaceutical, Biotechnology, Biotechnology Research | Other 19 Mar 2024 | | |
 Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Other 11 Mar 2024 | | |
 Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Atlanpole Biotherapies Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Not capitalistic Not partnership Event 6 Jun 2019 | | |
 Assurance Maladie Insurance, Government Administration | Assurance Maladie Insurance, Government Administration | Other 5 Jul 2017 | | |
 Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Other 19 Jun 2019 | | |
 Atlanpole Business Consulting and Services | Atlanpole Business Consulting and Services | Capitalistic Not partnership Not event 13 Nov 2017 | | |
 Omnes Startup accelerator & VC, Financial Services | Omnes Startup accelerator & VC, Financial Services | Capitalistic Not partnership Not event 15 Nov 2017 | | |